News | April 27, 2023
Syngene International posts Q4 FY2023 consolidated profit at Rs. 178.7 Cr
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Apollo continues to invest in genomics technology and research for better patient care
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
SÜDPACK is setting standards in terms of both performance and sustainability
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Several late-stage pipeline products have the potential to address some of these unmet needs
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators
The blood test market worldwide is today around $75-80 billion
Subscribe To Our Newsletter & Stay Updated
